ABBVIE INC. vs. Oragenics Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 6 compared factors.
Size & Scale
| ABBV | OGEN | |
|---|---|---|
| Market Cap | $470.55 billion | $2.16 million |
| Revenue (TTM) | $64.39 billion | — |
| Net Income (TTM) | $6.32 billion | $-10,083,409 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | OGEN | |
|---|---|---|
| P/E Ratio | 75.22 | — |
| Price / Book | -79.92 | 0.59 |
| Price / Sales | 7.31 | — |
ABBV leads on 1 of 1 valuation factors.
Profitability
| ABBV | OGEN | |
|---|---|---|
| Net Margin | 9.81% | — |
| Return on Equity | -107.29% | -274.70% |
ABBV leads on 1 of 1 profitability factors.
Dividend
| ABBV | OGEN | |
|---|---|---|
| Dividend Yield | 2.60% | — |
| Payout Ratio | 195.48 | — |
ABBV and OGEN split the dividend factors evenly.
Risk & Sentiment
| ABBV | OGEN | |
|---|---|---|
| Short Interest | 0.85% | 6.36% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, OGEN overview, OGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.